Metabolic-associated fatty liver disease

This is a meeting report of the 3rd Translational Hepatology Meeting held in Alicante, Spain, in October 2021. The meeting, which was organized by the Spanish Association for the Study of the Liver (AEEH), provided an update on the recent advances in the field of basic and translational hepatology,...

Descripción completa

Detalles Bibliográficos
Autores: Gallego-Durán, Rocío, Albillos, Agustín|||0000-0001-9131-2592, Ampuero, Javier|||0000-0002-8332-2122, Arechederra, María, Bañares, Rafael|||0000-0002-0412-8437, Blas-García, Ana, Berná, Genoveva, Caparrós, Esther, Cardoso Delgado, Teresa, Falcón-Pérez, Juan M.|||0000-0003-3133-0670, Francés, Rubén, Fernández-Barrena, Maite G., Graupera, Isabel|||0000-0001-9170-9784, Iruzubieta, Paula|||0000-0001-9476-1801, Nevzorova, Yulia A., Nogueiras, Rubén|||0000-0002-9976-9930, Macías, Rocío I.R., Martín, Franz, Sabio, Guadalupe|||0000-0002-2822-0625, Soriano, German|||0000-0002-9267-6811, Vaquero, Javier, Cubero, Francisco Javoer, Gracia-Sancho, Jordi|||0000-0001-7736-4089
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:280885
Acceso en línea:https://ddd.uab.cat/record/280885
https://dx.doi.org/urn:doi:10.1016/j.gastrohep.2022.02.005
Access Level:acceso abierto
Palabra clave:MAFLD
MASH
Steatohepatitis
Fibrosis
Hepatocellular carcinoma
Descripción
Sumario:This is a meeting report of the 3rd Translational Hepatology Meeting held in Alicante, Spain, in October 2021. The meeting, which was organized by the Spanish Association for the Study of the Liver (AEEH), provided an update on the recent advances in the field of basic and translational hepatology, with a particular focus on the molecular and cellular mechanisms and therapeutic targets involved in metabolic-associated fatty liver disease (MAFLD), metabolic-associated steatohepatitis (MASH), cirrhosis and end-stage hepatocellular carcinoma (HCC).